Organism name | Panax japonicus |
---|---|
Genus | Panax |
Family | Araliaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Panax japonicus |
---|---|
Linked NCBI taxonomy ID | 44685 |
Linked level | species |
Family in NCBI taxonomy | Araliaceae |
---|---|
ID | 4050 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003518
![]() |
Ginsenoside Re
|
CHEMBL510095
|
C049864
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
![]() |
C00046535
![]() |
Yesanchinoside I
/ (-)-Yesanchinoside I |
No. 11 | No. 51 |
![]() |
||||
C00003535
![]() |
Ginsenoside R1
/ Notoginsenoside R1 |
CHEMBL507115
|
C072936
|
No. 11 | No. 51 |
![]() |
||
C00030394
![]() |
Ginsenoside Rb1
/ Sanchinoside E1 / Sanchinoside Rb1 |
CHEMBL501515
|
2 / 0 / 0 | No. 11 | No. 51 |
![]() |
||
C00030396
![]() |
Gypenoside IV
/ Ginsenoside Rb3 |
CHEMBL449303
CHEMBL507688 CHEMBL452438 |
C044463
|
2 / 0 / 0 | No. 11 | No. 51 |
![]() |
|
C00030397
![]() |
Ginsenoside Rc
|
CHEMBL451702
|
C044462
|
No. 11 | No. 51 |
![]() |
||
C00030398
![]() |
Ginsenoside Rd
|
CHEMBL473659
|
C049863
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
![]() |
C00030842
![]() |
Notoginsenoside Fa
|
CHEMBL447915
|
No. 11 | No. 51 |
![]() |
|||
C00030843
![]() |
Notoginsenoside Fc
|
No. 11 | No. 51 |
![]() |
||||
C00030844
![]() |
Notoginsenoside Fe
|
No. 11 | No. 51 |
![]() |
||||
C00030845
![]() |
Notoginsenoside G
/ (+)-Notoginsenoside G |
No. 11 | No. 51 |
![]() |
||||
C00030858
![]() |
Notoginsenoside R4
/ (+)-Notoginsenoside R4 |
No. 11 | No. 51 |
![]() |
||||
C00030859
![]() |
Notoginsenoside R6
/ (+)-Notoginsenoside R6 |
CHEMBL494056
|
No. 11 | No. 51 |
![]() |
|||
C00046533
![]() |
Yesanchinoside G
/ (+)-Yesanchinoside G |
No. 11 | No. 51 |
![]() |
||||
C00045457
![]() |
Yesanchinoside B
/ (+)-Yesanchinoside B |
No. 11 | No. 51 |
![]() |
||||
C00045461
![]() |
Yesanchinoside F
/ (+)-Yesanchinoside F |
No. 11 | No. 51 |
![]() |
||||
C00045460
![]() |
Yesanchinoside E
/ (+)-Yesanchinoside E |
No. 11 | No. 51 |
![]() |
||||
C00045440
![]() |
Vina-Ginsenoside R6
|
CHEMBL449140
|
No. 11 | No. 51 |
![]() |
|||
C00045458
![]() |
Yesanchinoside C
/ (+)-Yesanchinoside C |
No. 11 | No. 51 |
![]() |
||||
C00046536
![]() |
Yesanchinoside J
/ (+)-Yesanchinoside J |
No. 11 | No. 51 |
![]() |
||||
C00045456
![]() |
Yesanchinoside A
/ (+)-Yesanchinoside A |
No. 32 | No. 51 |
![]() |
||||
C00045459
![]() |
Yesanchinoside D
/ (+)-Yesanchinoside D |
No. 32 | No. 51 |
![]() |
||||
C00045439
![]() |
Vina-ginsenoside R2
|
CHEMBL448234
|
No. 32 | No. 51 |
![]() |
|||
C00003520
![]() |
Ginsenoside Rg1
|
CHEMBL501637
CHEMBL1977916 |
C035054
|
5 / 6 | No. 32 | No. 51 |
![]() |
|
C00045438
![]() |
Vina-ginsenoside R1
|
CHEMBL509866
CHEMBL1869676 |
No. 32 | No. 51 |
![]() |
|||
C00046534
![]() |
Yesanchinoside H
|
No. 99 |
![]() |
|||||
C00031489
![]() |
1,8-Heptadecadiene-4,6-diyne-3,10-diol
|
CHEMBL463807
CHEMBL448210 |
C056818
|
No. 940 | No. 69 |
![]() |
||
C00030922
![]() |
Panaxydol
/ (-)-Panaxydol |
C055778
|
6 / 1 | No. 3682 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P11387 | DNA topoisomerase 1 | Isomerase | C00003518 C00030394 C00030396 C00030398 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003518 C00030394 C00030396 C00030398 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003520
C00030922
|
174 | AFP, FETA, HPAFP | alpha-fetoprotein |
C00030922
|
898 | CCNE1, CCNE | cyclin E1 |
C00003520
|
3757 | KCNH2, ERG1, HERG, HERG1, Kv11.1, LQT2, SQT1 | potassium voltage-gated channel, subfamily H (eag-related), member 2 |
C00003520
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00003520
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00003520
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00030922
|
3397 | ID1, ID, bHLHb24 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
C00030922
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00030922
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00030922
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006948 | Hyperkinesis |
C00003520
C00003518 |
D007859 | Learning Disorders |
C00003520
|
D003704 | Dementia |
C00003520
|
D007249 | Inflammation |
C00003520
|
D003928 | Diabetic Nephropathies |
C00003520
|
D008569 | Memory Disorders |
C00003520
|
D007674 | Kidney Diseases |
C00030398
|
D006528 | Carcinoma, Hepatocellular |
C00030922
|